Palvella Stock Up 340% as Insider Sells Shares. Here's What the Move Does (And Does Not) Signal

An executive at Palvella Therapeutics reported selling 4,302 common shares for approximately $508,000 on March 18, 2026. The disposal resulted from the immediate sale of shares acquired through option exercise.